Giredestrant for Estrogen Receptor–Positive, HER2-Negative, Previously Treated Advanced Breast Cancer: Results From the Randomized, Phase II acelERA Breast Cancer Study Patients with either MRD (≥1 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results